Russell Investments Group, Ltd.

Position in CAPR — Capricor Therapeutics, Inc.

CIK 1692234 Seattle, WA

Position in CAPR

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$344,102

+$204,841 QoQ

Shares Held

14,290

+211.9% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#97

of 169 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. CAPR ranks #162 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$344,102	14,290	+211.9%	Shares	Defined	2026-08-06
2026-03-31	$139,261	4,581	-1.3%	Shares	Defined	2026-05-08
2025-12-31	$133,910	4,640	-8.4%	Shares	Defined	2026-02-17
2025-09-30	$36,525	5,066	+122.2%	Shares	Defined	2025-11-13
2025-06-30	$22,640	2,280	+8.5%	Shares	Defined	2025-08-13
2025-03-31	$19,938	2,101	-54.8%	Shares	Defined	2025-05-13
2024-12-31	$64,197	4,652	+172.8%	Shares	Defined	2025-02-13
2024-09-30	$25,933	1,705	—	Shares	Defined	2024-11-13
No filing history on record for this holder in this stock.